Novo Nordisk B A/S

NOVO-B 
(NasdaqOMXC) 
 

Company Profile

Description
Novo Nordisk er en af verdens førende virksomheder inden for diabetesbehandling. De har et af branchens bredeste sortimenter af diabetesprodukter – herunder de mest avancerede systemer til dosering af insulin. De har desuden en førende position inden for andre områder som blødningsbehandling, væksthormonbehandling og hormonpræparater til behandling af klimakterielle gener. Novo Nordisk udvikler, fremstiller og markedsfører farmaceutiske produkter og serviceydelser, som gør en væsentlig forskel for patienter, behandlere og samfundet.
Key Stats
Website:
Headquarter country:
Employees: 35.000
Market Cap (at close 21-03-2019): DKK 823B
Fiscal Year Ends: december

Stats



Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return of Assets
Return on Equity
Return on Invested Capital
20182017201620152014

18,9021,6017,3031,3026,50 17,9020,2016,2025,6023,00 23,0021,9016,8033,8026,40 36,2038,2040,1041,3035,90 76,0080,2082,2079,9063,90 73,8078,6081,1078,3063,10

Dividend


Dividend/Share
Ex. Dividend Date
Trailing Dividend Yield
Payout Ratio

7,90
31-12-2018
2,42
49,28
Date Currency Amount
30-09-2018DKK3,00
31-03-2018DKK4,85
30-09-2017DKK3,00
31-03-2017DKK4,60
30-09-2016DKK3,00
31-03-2016DKK6,40

Income Statement DKKm



Revenue
Total Revenue
Gross Profit
Gross Margin %
EBITDA
Net Income
Basic Earnings Per Share

Operating Expenses
Operating Income
Operation Margin %
20182017201620152014


111.831,00111.696,00111.780,00107.927,0088.806,00 94,2194,0694,6091,7474,24 84,25%84,21%84,63%85,00%83,60% 53.295,0051.952,0051.056,0046.509,0037.570,00 38.628,0038.130,0037.925,0034.860,0026.481,00 15,96


15,42


14,99


13,56


10,10


46,9745,1046,1742,3039,75 47,2548,9748,4349,4434,49 42,25%



43,84%



43,33%



45,81%



38,84%



Cash Flow DKKm



Operating Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow
20182017201620152014


44.616,0041.168,0048.314,0038.287,0031.692,00 -12.410,00-8.648,00-8.267,00-6.406,00-4.335,00 32.206,0032.520,0040.047,0031.881,0027.357,00

Balance Sheet DKKm



Assets
Current Assets
Long Term Assets
Total Assets

Liabilities
Total Current Liabilities
Long Term Liabilities
Total Liabilities

Equity
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets
31-12-201831-12-201731-12-201631-12-201531-12-2014


59.067,0060.080,0059.766,0055.140,0046.293,0042.058,00 51.702,0042.275,0037.773,0036.659,0030.769,0028.279,00 110.769,00




102.355,00




97.539,00




91.799,00




77.062,00




70.337,00




54.164,0047.056,0047.436,0040.873,0033.689,0024.225,00 4.834,003.957,00









52.270,00




44.830,00









53.406,0048.977,0046.111,0046.816,0041.277,0041.137,00 11,0011,009,0010,0011,0021,00 51.839,0049.815,0045.269,0046.969,0040.294,0042.569,00 46.694,0046.490,0042.555,0044.811,0038.916,0040.954,00

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. marts 2019 08:08:32
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190320.1 - EUROWEB1 - 2019-03-23 08:08:32 - 2019-03-23 08:08:32 - 1 - Website: OKAY